| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000039606 |
| Receipt No. | R000045170 |
| Scientific Title | Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negative |
| Date of disclosure of the study information | 2020/03/01 |
| Last modified on | 2020/02/26 (Ver. 1) |
| Basic information | ||
| Public title | Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negative | |
| Acronym | Follow up study of the POTENT trial | |
| Scientific Title | Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negative | |
| Scientific Title:Acronym | Follow up study of the POTENT trial | |
| Region |
|
|
| Condition | ||
| Condition | Breast Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the survival and information about subsequent treatment after the POTENT trial |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | Disease-free survival, Cause of death, Site of recurrence, Treatment for recurrence, incidence of secondary cancer, treatment for secondary cancer |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients included in POTENT trial (UMIN000003969) | |||
| Key exclusion criteria | Patients excluded from POTENT trial (UMIN000003969) | |||
| Target sample size | 1930 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate school of medicine, Kyoto University | ||||||
| Division name | Breast Surgery | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54, Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan | ||||||
| TEL | 075-751-3660 | ||||||
| toi@kuhp.kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyoto University Hospital | ||||||
| Division name | Breast Surgery | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54, Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan | ||||||
| TEL | 075-751-3660 | ||||||
| Homepage URL | |||||||
| masahiro@kuhp.kyoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Breast Surgery, Graduate school of medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Taiho Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto University Graduate School and Faculty of Medicine, Ethics Committee |
| Address | Yoshida Konoe, Sakyo-ku, Kyoto, Japan |
| Tel | 075-753-4680 |
| ethcom@kuhp.kyoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | To investigate the survival and information about subsequent treatment after the POTENT trial |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045170 |